Table 5 Clinical outcomes
Variable | All patients | Positive test | ||||
|---|---|---|---|---|---|---|
Intervention group | Control group | p value | Intervention group | Control group | p value | |
(n = 100) | (n = 100) | (n = 19) | (n = 25) | |||
Post-infection LOS (days), median (IQR) | 19 (9–38) | 16 (9–31) | 0.355** | 20 (10–40) | 17 (9–31) | 0.317** |
Delta SOFA | 2 (0–3) | 2 (0–3) | 0.882** | 2 (0–3) | 2 (0–3) | 0.266** |
Mortality | ||||||
10 days | 22 (22%) | 28 (28%) | 0.327* | 4 (21.1%) | 4 (16.0%) | 0.710* |
28 days | 40 (40%) | 47 (47%) | 0.318* | 7 (36.8%) | 11 (44.0%) | 0.632* |
Hospital | 55 (55%) | 61 (61%) | 0.390* | 8 (42.1%) | 16 (64.0%) | 0.149* |